Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis

EUROPEAN HEART JOURNAL

OXFORD UNIV PRESS

1. MSD
2. British Heart Foundation [ISRCTN71907627]
3. Bayer
4. AstraZeneca
5. Boehringer-Ingelheim
6. Daiichi Sankyo
7. Eli-Lilly
8. Medtronic
9. Menarini group
10. Novartis
11. Servier
12. Vifor Pharma
13. Boston Scientific
14. Sanofi Aventis
15. Austrian Science Fund
16. Austrian Cardiology Society
17. Austrian Hypertension League
18. Bristol-Meyer-Squibb
19. Lilly Company
20. Merck Sharp and Dhome
21. BMS
22. Pfizer
23. British Heart Foundation [SP/12/2/29422] Funding Source: researchfish
24. Medical Research Council [G1002605] Funding Source: researchfish
25. MRC [G1002605] Funding Source: UKRI